Company Number: 12566225

Analysis Date: 2025-07-20 13:03 UTC

Financial Health Assessment for Bond Development Group Limited

---

1. Financial Health Score: D

Explanation:
The company shows signs of financial distress, primarily due to negative net current assets and shareholders' funds as of the latest financial year. The presence of a working capital deficit and accumulated losses indicates challenges in liquidity and equity stability. While the company is still operational and has no overdue filings, its financial "vital signs" reveal symptoms that warrant close monitoring and corrective action.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Current Assets	£260,157	Adequate short-term assets, largely stock
Cash in Hand	£852	Critically low cash reserves, "weak pulse"
Current Liabilities	£263,773	High short-term obligations
Net Current Assets	-£3,616	Negative working capital, "symptom of cash flow strain"
Shareholders' Funds	-£3,616	Negative equity, "sign of distress"
Share Capital	£30	Nominal share capital, typical for small startups
Loan from Related Party	£121,775	Significant interest-free loan from related company, reliance on intra-group support

Interpretation:

• The negative net current assets suggest the company may struggle to meet short-term debts without additional financing or asset sales.
• Very low cash on hand indicates tight liquidity, akin to a weak heartbeat in financial terms.
• Negative shareholders’ funds reflect accumulated losses exceeding initial capital, a sign of financial erosion.
• The company’s reliance on interest-free loans from a related company and directors is a critical support mechanism but could mask underlying operational issues.
• No employees are currently recorded, which may reduce overhead but also limits operational capacity.

---

3. Diagnosis

Bond Development Group Limited is currently in a financially fragile state. The company's "vital signs" suggest a liquidity crunch and balance sheet weakness. The high stock level (£259,305) shows significant work in progress or inventory, but this is illiquid and may not convert quickly to cash.

The negative net current assets and shareholders' funds are "symptoms of distress" indicating the company has absorbed losses that have eroded its equity base. While the business is not in formal insolvency processes (liquidation, administration), the financial structure resembles a patient with low blood pressure and poor circulation—at risk without intervention.

The reliance on interest-free loans from a related party and directors is helping sustain operations but is not a sustainable substitute for healthy cash flow or profitability.

---

4. Recommendations

Short-term Actions:

• Improve Cash Flow: Focus on converting stock/work in progress into cash through accelerated project completion and invoicing. Consider negotiating extended payment terms with suppliers to ease immediate cash pressure.
• Monitor Creditors: Engage proactively with creditors, especially related parties, to manage repayment expectations and avoid strained relationships.

Medium-term Strategies:

• Capital Injection: Consider raising additional equity or external financing to restore positive shareholders’ funds and strengthen the balance sheet. This will improve the company’s "immune system."
• Cost Control: Review operational expenses to reduce overhead and preserve cash without compromising growth potential.

Long-term Considerations:

• Operational Review: Assess project profitability and management efficiency to avoid recurring losses.
• Financial Planning: Implement robust budgeting and cash flow forecasting to anticipate funding needs and avoid liquidity crises.

---

Executive Summary